Buprenorphine Hcl Tablet
Product Images NDC 58118-0177

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl (NDC 58118-0177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine 2

Clinical Solutions Wholesale is a company based in Franklin, TN, USA that repacked and/or distributed uprenorphine SL 2mg Tablets by Hikma Pharmaceuticals USA with Lot #: SAMPLE123 Batch #: SAMPLE456 and an expiration date of 2021 Jul. The product has a National Drug Code (NDC) number of 00054-0176-13 and a Global Trade Item Number (GTIN) of 0035811801768. The product comes in a package of 30 tablets with a Drug Code (DC) of 58118-0176-8. The location of the manufacturer is in Eatontown, NJ, USA, 07724.*

FDA Label Image

Buprenorphine 8

This is a label for a medication called Buprenorphine SL 8mg Tablets, with the NDC code 58118-0177-8 and 30 tablets in the package. There is also information about Mig, with the NDC code 00054-0177-13, lot number SAVPLET23, batch number SAMPLE4S6, and expiration date of July 2021. The medication was manufactured by West-Ward Pharmaceuticals in Eatontown, NJ, and repackaged/distributed by Clinical Solutions Wholesale in Franklin, TN.*

FDA Label Image

Buprenorphine-hcl-chem-figure.jpg (Buprenorphine HCl Chem Figure)

FDA Label Image

Buprenorphine-medguide-graphic.jpg (Buprenorphine Medguide Graphic)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.